GEPIA analysis disclosed that breast cancer patients have significantly higher expression of AURKA (4.0 vs. 1.5), AURKB (4 vs. 1), TTK (2.5 vs. 0.5), MELK (3.0 vs. 0.5), KIF20A (3.5 vs. 0.5) genes compared to healthy people. Here, AURKA is linked to breast carcinoma.